Buisiness Overview


Our Mission

In response to the mission of Daiichi Sankyo Global R&D, creating innovative pharmaceuticals for unmet medical needs, Daiichi Sankyo RD Novare is pursuing “Process Innovation”, which, we believe, leads to the realization of highly productive technology/operational platforms for drug discovery and development.

Research Development

The improved productivity of the early-stage exploratory research leveraged by the seamless integration of technologies for acquisition ofvalidated hits and biomarker research, Operational excellence of clinical trials with robustness against various environmental changes which may have negative impacts on cost and time-line